First description of Nodding Syndrome in the Central African Republic.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
18
11
2020
accepted:
30
04
2021
revised:
30
06
2021
pubmed:
19
6
2021
medline:
21
10
2021
entrez:
18
6
2021
Statut:
epublish
Résumé
The term Nodding Syndrome (NS) refers to an atypical and severe form of childhood epilepsy characterized by a repetitive head nodding (HN). The disease has been for a long time limited to East Africa, and the cause is still unknown. The objective of this study was to confirm the existence of NS cases in Central African Republic (CAR). This was a cross-sectional descriptive study in the general population. The identification of NS cases was conducted through a door-to-door survey in a village near Bangui along the Ubangui River. Based on Winkler's 2008 and the World Health Organization (WHO)'s 2012 classifications, the confirmation of cases was done by a neurologist who also performed the electroencephalograms. No laboratory tests were done during this investigation. Treatment was offered to all patients. A total of 6,175 individuals was surveyed in 799 households. After reviewing the cases, we identified 5 NS cases in girls aged between 8 and 16. The age of onset of the seizures was between 5 and 12 years of age. Two cases were classified as "HN plus" according to Winkler's 2008 classification. Four NS cases were classified as probable and one as confirmed according to the WHO's 2012 classification. Three of them presented with developmental delay and cognitive decline, and one had an abnormally low height-for-age z-score. Electroencephalographic abnormalities were found in four patients. Nodding Syndrome cases were described in CAR for the first time. Despite certain peculiarities, these cases are similar to those described elsewhere. Given that only a small part of the affected area was investigated, the study area along the Ubangui River needs to be expanded in order to investigate the association between Onchocerca volvulus and NS and also evaluate the real burden of NS in CAR.
Sections du résumé
BACKGROUND
The term Nodding Syndrome (NS) refers to an atypical and severe form of childhood epilepsy characterized by a repetitive head nodding (HN). The disease has been for a long time limited to East Africa, and the cause is still unknown. The objective of this study was to confirm the existence of NS cases in Central African Republic (CAR).
METHODOLOGY/PRINCIPAL FINDINGS
This was a cross-sectional descriptive study in the general population. The identification of NS cases was conducted through a door-to-door survey in a village near Bangui along the Ubangui River. Based on Winkler's 2008 and the World Health Organization (WHO)'s 2012 classifications, the confirmation of cases was done by a neurologist who also performed the electroencephalograms. No laboratory tests were done during this investigation. Treatment was offered to all patients. A total of 6,175 individuals was surveyed in 799 households. After reviewing the cases, we identified 5 NS cases in girls aged between 8 and 16. The age of onset of the seizures was between 5 and 12 years of age. Two cases were classified as "HN plus" according to Winkler's 2008 classification. Four NS cases were classified as probable and one as confirmed according to the WHO's 2012 classification. Three of them presented with developmental delay and cognitive decline, and one had an abnormally low height-for-age z-score. Electroencephalographic abnormalities were found in four patients.
CONCLUSIONS/SIGNIFICANCE
Nodding Syndrome cases were described in CAR for the first time. Despite certain peculiarities, these cases are similar to those described elsewhere. Given that only a small part of the affected area was investigated, the study area along the Ubangui River needs to be expanded in order to investigate the association between Onchocerca volvulus and NS and also evaluate the real burden of NS in CAR.
Identifiants
pubmed: 34143783
doi: 10.1371/journal.pntd.0009430
pii: PNTD-D-20-02016
pmc: PMC8244846
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0009430Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Pathogens. 2020 Apr 30;9(5):
pubmed: 32365847
BMJ Open. 2013 May 03;3(5):
pubmed: 23645924
Am J Trop Med Hyg. 2018 Nov;99(5):1211-1218
pubmed: 30226148
Epilepsia. 2008 Dec;49(12):2008-15
pubmed: 18503562
MMWR Morb Mortal Wkly Rep. 2014 Jul 18;63(28):603-6
pubmed: 25029112
PLoS Negl Trop Dis. 2017 Feb 9;11(2):e0005201
pubmed: 28182652
MMWR Morb Mortal Wkly Rep. 2012 Jan 27;61(3):52-4
pubmed: 22278159
Vital Health Stat 11. 2002 May;(246):1-190
pubmed: 12043359
Epilepsy Behav. 2019 Jan;90:70-78
pubmed: 30513438
Emerg Infect Dis. 2013;19(9):1374-84
pubmed: 23965548
Trop Doct. 2010 Jul;40(3):173-5
pubmed: 20555049
PLoS One. 2013 Jun 18;8(6):e66419
pubmed: 23823012
Infect Dis Poverty. 2018 Mar 22;7(1):23
pubmed: 29580280
BMJ Open. 2014 Nov 14;4(11):e006476
pubmed: 25398677
eNeurologicalSci. 2015 Nov 07;3:80-83
pubmed: 29430539
Nat Rev Neurol. 2018 Nov;14(11):632
pubmed: 30262930
Epilepsia. 2005 Apr;46(4):470-2
pubmed: 15816939
Lancet Neurol. 2003 Dec;2(12):714
pubmed: 14649236
Int J Infect Dis. 2016 Apr;45:112-7
pubmed: 26987477
Seizure. 2015 Sep;31:64-71
pubmed: 26362379
Epileptic Disord. 2018 Dec 1;20(6):508-516
pubmed: 30530420
Afr Health Sci. 2012 Sep;12(3):242-8
pubmed: 23382736
PLoS Negl Trop Dis. 2019 Jul 17;13(7):e0007300
pubmed: 31314757
Lancet Neurol. 2013 Feb;12(2):166-74
pubmed: 23305742